Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer

Journal of Surgical Oncology

Volumn 92, Issue 1, 2005, Pages 4-8

  Agarwal, Anurag ^a   Heron, Dwight E ^a,c   Sumkin, Jules ^b   Falk, Jeff ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Contralateral uptake; Recurrent breast cancer; Sentinel lymph node mapping

Indexed keywords

DOXORUBICIN; FLUOROURACIL; IRIDIUM 192; METHOTREXATE; METHYLENE BLUE; TAMOXIFEN; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; BRACHYTHERAPY; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CANCER STAGING; CASE REPORT; DRUG UPTAKE; FEMALE; HOT FLUSH; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAMMOGRAPHY; OVARIECTOMY; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION DOSE; SENTINEL LYMPH NODE; ULTRASOUND;

ADULT; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 26244434908     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20282     Document Type: Article

References (27)

1. Clark GM: Prognostic and predictive factors. In: Harris JR, et al., editors. Diseases of the breast. Philadelphia, PA: Lippincott Williams & Wilkins, 1999. 490p.
2. Giuliano AE: Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 2001;(9S):52S-55S.
3. Anderson BO, Austin-Seymour MM, Gralow JR, et al.: A multidisciplinary approach to locoregional management of the axilla for primary operable breast cancer. Cancer Control 1997;4:491-499.
4. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
5. Giuliano AE, Haigh PI, Brennan MB, et al.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-2559.
6. McMasters KM, Tuttle TN, Carlson DJ, et al.: Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2001;18:2560-2566.
7. Nieweg OE, Rutgers EJ, Jansen L, et al.: Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001;25:780-788.
8. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edn. Philadelphia, PA: Lippincott-Raven, 2002.
9. American Society of Breast Surgeons: http://www.breastsurgeons.org/ sentinel.shtml, Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer. November 1, 2002.
10. Deutsch M: Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 2002;53:687-691.
11. Krag D, Weaver D, Ashikaga T, et al.: The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-946.
12. Hill AD, Tran KN, Akhurst T, et al.: Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 2000; 229:528-535.
13. Cox CE, Pendas S, Cox JM: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-653.
14. De Cicco C, Cremonesi M, Luini A, et al.: Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;3:2080-2084.
15. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1997;220:391-401.
16. Giuliano AE, Jones RC, Brennan M, et al.: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
17. Borgstein PJ, Pijpers R, Comans EF, et al.: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.
18. Koller M, Barsuk D, Zippel D, et al.: Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol 1998;24:166-168.
19. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-340.
20. Albertini JJ, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1997;276:1818-1822.
21. Galimberti V, Zurrida S, Veronesi P, et al.: Can sentinel lymph node biopsy avoid axillary dissection in NO breast cancer patients? Breast Cancer Res Treat 1997;46:24. (abstract 6).
22. Shons A, Joseph E, Cox CE, et al.: Predictors of sentinel lymph node metastases in the lymphatic mapping of breast cancer patients. Breast Cancer Res Treat 1997;46:24. (abstract 5).
23. Morrow M, Harris JR: Local management of invasive breast cancer. In: Harris JR, et al., editors. Disease of the breast. Philadelphia, PA: Lippincott Williams & Wilkins, 1999. 549p.
24. Fisher B, Wolmark N, Bauer M, et al.: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-772.
25. ACOSOG Semiannual Meeting. Z0011 trial, 10/20/02 update Htpp://www.acosog.org.
26. Wolmark N, Chairperson: NSABP Protocol B-32: A randomized, phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. 2/11/1999.
27. Morrow M, Foster RS, Jr.: Staging of breast cancer: A new rationale for internal mammary node biopsy. Arch Surg 1981; 116:748-751.